Association of Serum Uric Acid-to-high-density Lipoprotein Cholesterol Ratio with Non-alcoholic Fatty Liver Disease in American Adults: a Population-based Analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 May 31

PMID 37256087

Authors

Yilian Xie

Kai Huang

Xiangyu Zhang

Zhouxiao Wu

Yiyi Wu

Jinguo Chu

Weiliang Kong

Guoqing Qian

Affiliations

Soon will be listed here.

Abstract

Objective: Non-invasive disease indicators are currently limited and need further research due to the increased non-alcoholic fatty liver disease (NAFLD) prevalence worldwide. The serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) has been recognized as a novel inflammatory and metabolic marker. Herein, we explored the correlation between UHR and the risk of NAFLD in-depth.

Methods: A total of 3,766 participants were included in our survey, and the National Health and Nutrition Examination Survey (NHANES) 2017-2018 cycle provided the cross-sectional study population. Weighted multivariable logistic regression and multivariate linear regression analyses were performed to assess the association between the UHR and the odds of NAFLD and liver steatosis and fibrosis severity, respectively. Moreover, we explored the non-linear relationship between the UHR and NAFLD by the generalized additive model.

Results: NAFLD probabilities were statistically demonstrated to be positively correlated with the UHR (OR = 1.331 per SD increase, 95% CI: 1.100, 1.611). The positive connection of the UHR with NAFLD risk persisted significantly in female subjects but not in male subjects in subgroup analyses stratified by gender. The non-linear relationship analysis demonstrated that a UHR between ~20 and 30% suggested a saturation effect of NAFLD risk. Furthermore, a dramatically positive correlation was found between the UHR and hepatic steatosis severity but not fibrosis. Finally, the receiver operating characteristic analysis suggested that UHR had a better predictive value for NAFLD than either serum uric acid (sUA) or high-density lipoprotein cholesterol (HDL) alone [UHR (area under curve): 0.6910; 95% CI: 0.6737-0.7083; < 0.0001].

Conclusion: Our investigation revealed that the elevated UHR level was independently related to an increased NAFLD risk and the severity of liver steatosis in American individuals. The correlation differed according to sex. This non-invasive indicator may enhance the capacity to predict the onset of NAFLD and may uncover alternative therapeutic interventional targets.

Citing Articles

Association between uric acid/high-density lipoprotein cholesterol ratio and testosterone deficiency in adult American men: findings from the national health and nutrition examination survey 2011-2016.

Xia W, Xie P, Zhuang Q, Zhang M, Shao N, Chen Y BMC Public Health. 2025; 25(1):939.

PMID: 40065268 PMC: 11892185. DOI: 10.1186/s12889-025-22194-5.

Association between Hp infection and serum uric acid to high-density lipoprotein cholesterol ratio in adults.

Qin Z, Fang Y, Liu Y, Zhang L, Zhang R, Zhang S Front Med (Lausanne). 2025; 12:1509269.

PMID: 40018350 PMC: 11866119. DOI: 10.3389/fmed.2025.1509269.

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity.

Liu M, Cao B, Luo Q, Song Y, Liu K, Wu D Front Endocrinol (Lausanne). 2025; 15():1474384.

PMID: 39845880 PMC: 11750666. DOI: 10.3389/fendo.2024.1474384.

Alarmins in Chronic Spontaneous Urticaria: Immunological Insights and Therapeutic Perspectives.

Rizzi A, Li Pomi F, Inchingolo R, Viola M, Borgia F, Gangemi S Biomedicines. 2025; 12(12.

PMID: 39767672 PMC: 11673798. DOI: 10.3390/biomedicines12122765.

Association between the ratio of serum uric acid to high-density lipoprotein cholesterol and liver fat content: evidence from a Chinese health examination dataset.

Liu A, Sun Y, Qi X, Zhou Y, Zhou J, Li Z Sci Rep. 2024; 14(1):31397.

PMID: 39733068 PMC: 11682173. DOI: 10.1038/s41598-024-83013-2.

References

de Ledinghen V, Vergniol J, Foucher J, Merrouche W, Le Bail B . Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012; 32(6):911-8. DOI: 10.1111/j.1478-3231.2012.02820.x. View

Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

DiStefano J . NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment. Endocrinology. 2020; 161(10). PMC: 7473510. DOI: 10.1210/endocr/bqaa134. View

Kurtkulagi O, Atak Tel B, Kahveci G, Bilgin S, Duman T, Erturk A . Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021; 59(4):403-408. DOI: 10.2478/rjim-2021-0023. View

Fernandez Rodriguez C, Aller R, Gutierrez Garcia M, Ampuero J, Gomez-Camarero J, Martin-Mateos R . Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). Rev Esp Enferm Dig. 2019; 111(4):264-269. DOI: 10.17235/reed.2019.5965/2018. View

Fowler J, Tucker L, Bailey B, Lecheminant J . Physical Activity and Insulin Resistance in 6,500 NHANES Adults: The Role of Abdominal Obesity. J Obes. 2020; 2020:3848256. PMC: 7745049. DOI: 10.1155/2020/3848256. View

Castera L, Friedrich-Rust M, Loomba R . Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019; 156(5):1264-1281.e4. PMC: 7505052. DOI: 10.1053/j.gastro.2018.12.036. View

Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H . Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 2013; 49(11):1477-84. DOI: 10.1007/s00535-013-0911-1. View

Park B, Jung D, Lee Y . Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Incident Ischemic Heart Disease in Non-Diabetic Koreans. Biomedicines. 2022; 10(6). PMC: 9219787. DOI: 10.3390/biomedicines10061422. View

10.

Kontush A, de Faria E, Chantepie S, Chapman M . A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis. 2005; 182(2):277-85. DOI: 10.1016/j.atherosclerosis.2005.03.001. View

11.

Ciardullo S, Perseghin G . Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. Metabolism. 2021; 121:154752. DOI: 10.1016/j.metabol.2021.154752. View

12.

Le M, Yeo Y, Li X, Li J, Zou B, Wu Y . 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021; 20(12):2809-2817.e28. DOI: 10.1016/j.cgh.2021.12.002. View

13.

Aktas G, Kocak M, Bilgin S, Atak B, Duman T, Kurtkulagi O . Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2019; 23(5):1098-1102. DOI: 10.1080/13685538.2019.1678126. View

14.

Kocak M, Aktas G, Erkus E, Sincer I, Atak B, Duman T . Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019; 65(1):9-15. DOI: 10.1590/1806-9282.65.1.9. View

15.

Calcaterra V, Brambilla P, Maffe G, Klersy C, Albertini R, Introzzi F . Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab Syndr Relat Disord. 2014; 12(3):159-64. DOI: 10.1089/met.2013.0075. View

16.

Duan H, Zhang R, Chen X, Yu G, Song C, Jiang Y . Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study. Front Endocrinol (Lausanne). 2022; 13:930224. PMC: 9259838. DOI: 10.3389/fendo.2022.930224. View

17.

Chowdhury A, Mehta K . Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2022; 23(2):273-285. PMC: 10224864. DOI: 10.1007/s10238-022-00799-z. View

18.

Zipf G, Chiappa M, Porter K, Ostchega Y, Lewis B, Dostal J . National health and nutrition examination survey: plan and operations, 1999-2010. Vital Health Stat 1. 2014; (56):1-37. View

19.

Kim D, Konyn P, Cholankeril G, Ahmed A . Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol Hepatol. 2021; 20(6):e1438-e1455. DOI: 10.1016/j.cgh.2021.06.029. View

20.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View